-
Sinner rips Tiafoe to reach Miami Open semis
-
US lays it on the line as WTO mulls future of global trading
-
Joy, scepticism across west Africa after UN vote on slave trade
-
Salah would be 'asset' says San Diego FC owner
-
Parmesan exports doing grate... but sales melt in Italy
-
US cannot meet Iran war-induced LNG shortfall: industry leaders
-
Trump denies being 'desperate' for Iran deal
-
US envoy to UK warns against cancelling king's visit
-
IOC's new gender testing throws up multiple questions
-
Malinin back to his best as third world skating title beckons
-
Cuban children's heart hospital makes tough choices amid US blockade
-
Oil climbs, stocks slide on uncertainty over US-Iran talks
-
Nepal's PM-to-be delivers first post-election message in rap, urges unity
-
Vernon wins wind-hit Tour of Catalonia stage as Pidcock climbs to second
-
ChatGPT's taste for literary nonsense sparks alarm
-
Paul McCartney recalls Yesterday with first album in five years
-
'True miracle': Napoleon's long-lost hat to go on display
-
Lost in space: Sperm struggles to navigate during weightless sex
-
G7 meets in France hoping to heal transatlantic Iran rift
-
IOC's gender test directive throws up multiple questions
-
Trump insists Iran operations 'extremely' ahead of schedule
-
Bab al-Mandeb Strait: another key shipping route under threat
-
Families of Kabul bombing victims still search for answers
-
Police detain French ex-cop suspected of killing mothers of his children
-
Venezuela's Maduro back in court after stunning US capture
-
Senegal victims of 'most blatant scam' in football history: federation
-
Former badminton Olympic gold winner Marin retires due to injury
-
Olympic women's sport to be limited to biological females
-
Africa sets out stall for cotton at the WTO
-
Trump's Iran war tests MAGA 'America First' creed
-
What's happening with Iran-US 'talks'?
-
WTO mulls future of global trading under cloud of Mideast war
-
US flexes 'new order' trade policy as WTO meet kicks off
-
Germany unveils rescue plan for struggling chemical sector
-
UK PM 'very keen' to curb addictive social media after US ruling
-
South Africa disinvited from G7 in France after US pressure: Pretoria
-
EU moves closer to ban sexualised AI deepfakes
-
France bids farewell to ex-PM Jospin who 'modernised' nation
-
Belarus' Lukashenko gifts automatic rifle to North Korea's Kim
-
Germany bank on team spirit to end World Cup woes
-
Venezuela's Maduro back in US court after stunning capture
-
French court orders ex-bishop to pay over 1970s child sex abuse
-
PSG Ligue 1 game postponed in between two legs of Liverpool Champions League tie
-
Iran may believe it has the upper hand as Trump seeks talks
-
EU urged to broadly restrict 'forever chemicals'
-
Italy seizes millions 'embezzled' from Ursula Andress
-
Trump says Iran 'better get serious' in Mideast war talks
-
Global trading system hit by 'worst disruptions in the past 80 years': WTO chief
-
EU accuses four porn platforms of letting children access adult content
-
Cathay Pacific raises fuel surcharge on all flights by 34%
New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
O.Karlsson--AMWN